Search

everythinglearnresearchcommunity

for

Search:↓

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Laser treatment can effectively reduce unwanted hair growth, particularly for people with fair skin and dark hair.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Vitamins B3, B6, C, and iron intake affect hormone levels in women with certain types of PCOS.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Platelet-rich plasma infusion improved pregnancy outcomes for women with thin endometrium.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Old drugs are often used for new, different medical purposes in endocrine pharmacology.

Nanomaterials could improve PCOS treatment by delivering drugs more effectively with fewer side effects.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

More research is needed to confirm if natural products effectively treat PCOS.

PCOS increases sexual pain and distress in infertile Iranian women.

New ultrasound criteria for diagnosing PCOS in North African patients were successfully established.

Some medications and supplements can affect male fertility, with some improving and others harming sperm quality.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

Women with PCOS have higher body fat and skinfold thickness, especially in the H-O-POM phenotype.

Accurate diagnosis of hyperandrogenism, especially PCOS, is crucial for managing fertility and metabolic risks in women.